GlaxoSmithKline PLC
F:GS7
GlaxoSmithKline PLC
F:GS7
Price:
15.4
EUR
-0.67%
Market Cap:
€62.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
GlaxoSmithKline PLC
F:GS7
|
UK |
|
W
|
Wolverine World Wide Inc
F:WW4
|
US |
|
Petroleo Brasileiro SA Petrobras
BOVESPA:PETR4
|
BR |
|
L
|
Lamb Weston Holdings Inc
F:0L5
|
US |
|
Abivax SA
PAR:ABVX
|
FR |
|
M
|
Mentice AB
XBER:MN2
|
SE |
|
Lemonade Inc
F:LE0
|
US |
|
Abivax SA
NASDAQ:ABVX
|
FR |
Reverse DCF
Market Expectations:
Unrealistic
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|
Below current price
Above current price
